NUWE - Nuwellis Inc


1.29
-0.140   -10.853%

Share volume: 190,062
Last Updated: 03-09-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.02%

PREVIOUS CLOSE
CHG
CHG%

$1.43
-0.14
-0.10%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
41%
Profitability 35%
Dept financing 43%
Liquidity 47%
Performance 45%
Company vs Stock growth
vs
Performance
5 Days
-12.84%
1 Month
-49.81%
3 Months
-54.58%
6 Months
-68.61%
1 Year
2.38%
2 Year
-92.16%
Key data
Stock price
$1.29
P/E Ratio 
0.00
DAY RANGE
$1.20 - $1.42
EPS 
-$62.23
52 WEEK RANGE
$0.19 - $25.95
52 WEEK CHANGE
$6.61
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-06-2025
BETA 
2.89
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$68,954
AVERAGE 30 VOLUME 
$69,345
Company detail
CEO: Nestor Jaramillo
Region: US
Website: nuwellis.com
Employees: 70
IPO year: 2017
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Nuwellis, Inc. focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States.

Recent news